Trials / Unknown
UnknownNCT04347070
Implementation of Physiotherapy on COVID-19 Patients in ICU
Implementation of Physiotherapy on COVID-19 Patients in Intensive Care Units : a Retrospective, Multicentric, International Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (actual)
- Sponsor
- University Hospital, Montpellier · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Despite new charachersitics of COVID-19 patients, critical care implementation seems to be similar to those with Acute Respiratory Distress Syndrome (ARDS) in intensive care units (ICU). Regarding the initial gravity of these patients, sedation and neuromuscular blockers are usually administrated, increasing the risk to develope an ICU-acquired weakness which is directly correlated to morbi-mortality and a burden during recovery. Respiratory symptoms are mostly related to dyspnoea and non-productive cough, with only 33% of COVID-19 patient having a bronchial hypersecretion ; consequently, chest physiotherapy is only implemented in after case-by-case evaluation. This unprecedented situation requires to identify how physiotherapy is being implemented in COVID-19 patients in ICU. This retrospective, multicentric study aims to identify the charactheristics of physiotherapy (type and time spent) implemented in Argentina, Belgium, Chili, France, Italy and Spain
Detailed description
* Demographics data : hospitalisation date, ICU date, COVID+ date, extubation date, discharge date, mortality * ICU data : ventilatory mode, type of physiotherapy implemented (early rehabilitation, chest physiotherapy, time spent (minutes), number of interventions per day.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Phsyiotherapy | To observe if patients with COVID-19 benefice of physiothersapy, which kind and how many time |
Timeline
- Start date
- 2017-04-01
- Primary completion
- 2020-09-01
- Completion
- 2022-12-01
- First posted
- 2020-04-15
- Last updated
- 2020-12-29
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04347070. Inclusion in this directory is not an endorsement.